Search Results

Business

UroGen Secures Exclusive License from medac GmbH to Develop a Next-Generation Novel Mitomycin-Based Formulation for Urothelial Cancers

UroGen Pharma Ltd. today announced a licensing agreement with medac GmbH to develop a next-generation novel mitomycin-based formulation for urothelial cancers.

January 17, 2024

·

6 min read

Press Releases

Medexus and medac Conclude Negotiations to Amend US Treosulfan Agreement, Setting Regulatory Milestone Amounts and Payment Schedule

December 2, 2024

·

6 min read

Genetown

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

ArisGlobal, a market-leader in global drug development technology solutions, announced today that medac, a German-based pharmaceutical manufacturer specializing in the fields of oncology and hematology, urology, and autoimmune diseases, has chosen LifeSphere Safety to modernize its drug safety processes.

September 13, 2023

·

2 min read

Press Releases

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

November 25, 2024

·

4 min read

Deals

Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO

Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.

June 13, 2024

·

3 min read

Business

Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH

Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.

April 9, 2024

·

2 min read

Press Releases

FGK Clinical Research GmbH Highlights 3.5 Years of Success with Flex Databases

October 10, 2024

·

1 min read

FDA

FDA Accepts for Review Treosulfan NDA Resubmission

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) was informed by medac, licensor of Medexus’s commercialization rights to treosulfan, that the US Food and Drug Administration has accepted for review medac’s April 2024 resubmission of the New Drug Application for treosulfan.

June 6, 2024

·

5 min read

Drug Development

HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data

HD Immune GmbH announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.

January 23, 2024

·

2 min read

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada

Medexus Pharmaceuticals Inc. today announced that it has entered into a licensing agreement, formalizing its relationship with medac GmbH (“ medac ”) to commercialize treosulfan, a bifunctional alkylating agent, in Canada.

July 12, 2021

·

6 min read